MedPath

Impact Of Timing Of Drainage Of Massive Ascites On Operative And Post-Operative Course In Living-Donor Liver Transplant Recipients. A Prospective Randomized Controlled Trial.

Not Applicable
Completed
Conditions
Massive Ascites
Registration Number
NCT02867293
Lead Sponsor
Mansoura University
Brief Summary

Massive ascites is usually controlled over several weeks pre-operatively in liver transplant recipients with the risk of encephalopathy and peritonitis. We hypothesized that intra-operative drainage of ascites will be safe and avoids the inherent risks of pre-operative drainage.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • liver transplant candidates with tense acsites
Exclusion Criteria
  • severe coagulpathy (INR more than 2 or platlet count less than 50) MELD more than 20

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
graft survivalone year
Secondary Outcome Measures
NameTimeMethod
patient survivalone year

Trial Locations

Locations (1)

Mansoura university

🇪🇬

Mansoura, Dkahleya, Egypt

Mansoura university
🇪🇬Mansoura, Dkahleya, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.